Sri Lanka

Reimbursed Care Access

Sri Lanka maintains a highly restrictive, enforcement-heavy legal framework for classical psychedelics and novel psychoactives under the Poisons/Opium/Dangerous Drugs regime and overseen by the National Dangerous Drugs Control Board (NDDCB) and the National Medicines Regulatory Authority (NMRA). Ketamine is a legally available anesthetic and is used in Sri Lankan hospitals and some clinical research/off‑label settings, but licensed psychedelic medicines (e.g., psilocybin, MDMA, commercial esketamine products) do not have an established, reimbursed therapeutic pathway and recreational/unauthorised possession and trafficking are subject to severe criminal penalties and active enforcement actions.